Microbot Medical Inc.

NASDAQ:MBOT

Medical - Instruments & Supplies

Healthcare
$0.98 -2.93%

-$0.06 today

Market cap
$65.73M
Beta
1.04
P/E (TTM)
-8.6
EPS (TTM)
-$0.21
52W Low $1.60High $4.67

Volume 0.87M

Average 1.60M

MBOT Sales of Investments

Cash received from selling or redeeming investments.

Microbot Medical Inc.NASDAQ: MBOT

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments grows, but more slowly than its trailing trend

Q1 FY2026 sales of investments of $6.5M rose 96.9% year over year, behind the +125.0% change in trailing-twelve-month sales of investments. Sequentially, it rose 333.3% from the prior quarter.

Context

  • Sales of investments increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +96.9% toward the trailing-twelve-month pace of +125.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.5M+333.3% QoQ
Last fiscal yearDec 2025
$10.6M+58.7% YoY
LTMMar 2026
$13.8M+125.0% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+96.9%——
1 year+58.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
10.6M USD
Year-over-year change
+58.7%
4-year CAGR
+34.2%

Sales of Investments vs competitors

How MBOT compares with its peers on the latest reported figures

  • Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +125.0% is the highest of 5, against a peer median of -62.7%.
  • Sales of investments amounts to 13143.8% of revenue for MBOT, versus a peer median of 0.0%.
MBOT Competitors
Sales of Investments for MBOT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$81.13M USD-49.2%-19.4%—
OVIDOvid Therapeutics Inc.LTM Mar 2026$42M USD-61.1%-22.4%589.7%
RCELAVITA Medical, Inc.LTM Mar 2026$22.5M USD-64.3%-20.9%31.1%
MBOTMicrobot Medical Inc.LTM Mar 2026$13.8M USD+125.0%—13143.8%
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$0 CAD———
VANIVivani Medical, Inc.LTM Mar 2026$0 USD———
ZTEKZentek Ltd.LTM Mar 2026CA$0 CAD——0.0%
CLNNClene Inc.LTM Mar 2026$0 USD-100.0%—0.0%
DCGODocGo Inc.LTM Mar 2026$0 USD——0.0%
CNTXContext Therapeutics Inc.LTM Mar 2026$0 USD———
Peer median (excluding MBOT) —-62.7%-20.9%0.0%

Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Depreciation & Amortization76K102K106K91K47K
Deferred Income Tax00000
Stock-Based Compensation1.39M1.75M1.39M1.35M1.06M
Change in Working Capital497K(228K)(11K)942K(1.01M)
Accounts Receivables00000
Inventory0000(584K)
Accounts Payables00000
Other Working Capital497K(228K)(11K)942K(424K)
Other Non-Cash Items1.39M(7K)718K234K0
Operating Cash Flow(9.35M)(11.55M)(8.53M)(8.83M)(13.05M)
Capital Expenditures(69K)(84K)(33K)(25K)(60K)
Acquisitions (Net)00000
Purchases of Investments0(3.75M)(10.06M)(5.12M)(82.93M)
Sales of Investments3.27M012.06M6.68M10.6M
Other Investing Activities0(3K)3K00
Investing Cash Flow3.2M(3.84M)1.97M1.54M(72.38M)
Debt Repayment00000
Common Stock Issued04.32M6.56M7.94M86.24M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00000
Financing Cash Flow04.32M6.56M7.94M86.24M
Effect of Forex Changes00000
Net Change in Cash(6.15M)(11.06M)(2K)646K810K
Free Cash Flow(9.42M)(11.63M)(8.57M)(8.85M)(13.11M)

Microbot Medical Inc.

NASDAQ:MBOT

Intrinsic Alpha fair value

Locked

Current Price

$0.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.